Table of Content

1 Market Overview of Tumour Vaccine
1.1 Tumour Vaccine Market Overview
1.1.1 Tumour Vaccine Product Scope
1.1.2 Tumour Vaccine Market Status and Outlook
1.2 Global Tumour Vaccine Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Tumour Vaccine Market Size by Region (2024-2034)
1.4 Global Tumour Vaccine Historic Market Size by Region (2024-2024)
1.5 Global Tumour Vaccine Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Tumour Vaccine Market Size (2024-2034)
1.6.1 North America Tumour Vaccine Market Size (2024-2034)
1.6.2 Europe Tumour Vaccine Market Size (2024-2034)
1.6.3 Asia-Pacific Tumour Vaccine Market Size (2024-2034)
1.6.4 Latin America Tumour Vaccine Market Size (2024-2034)
1.6.5 Middle East & Africa Tumour Vaccine Market Size (2024-2034)
2 Tumour Vaccine Market by Type
2.1 Introduction
2.1.1 Personalized Vaccine
2.1.2 Off-the shelf Vaccine
2.2 Global Tumour Vaccine Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Tumour Vaccine Historic Market Size by Type (2024-2024)
2.2.2 Global Tumour Vaccine Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Tumour Vaccine Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Tumour Vaccine Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Tumour Vaccine Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Tumour Vaccine Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Tumour Vaccine Revenue Breakdown by Type (2024-2034)
3 Tumour Vaccine Market Overview by Application
3.1 Introduction
3.1.1 Lung Cancer
3.1.2 Melanoma Cancer
3.1.3 Gastrointestinal Cancer
3.1.4 Brain Cancer
3.1.5 Others
3.2 Global Tumour Vaccine Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Tumour Vaccine Historic Market Size by Application (2024-2024)
3.2.2 Global Tumour Vaccine Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Tumour Vaccine Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Tumour Vaccine Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Tumour Vaccine Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Tumour Vaccine Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Tumour Vaccine Revenue Breakdown by Application (2024-2034)
4 Tumour Vaccine Competition Analysis by Players
4.1 Global Tumour Vaccine Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tumour Vaccine as of 2022)
4.3 Date of Key Players Enter into Tumour Vaccine Market
4.4 Global Top Players Tumour Vaccine Headquarters and Area Served
4.5 Key Players Tumour Vaccine Product Solution and Service
4.6 Competitive Status
4.6.1 Tumour Vaccine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Tumour Vaccine Products, Services and Solutions
5.1.4 Pfizer Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.1.5 Pfizer Recent Developments
5.2 Merck & Co Inc
5.2.1 Merck & Co Inc Profile
5.2.2 Merck & Co Inc Main Business
5.2.3 Merck & Co Inc Tumour Vaccine Products, Services and Solutions
5.2.4 Merck & Co Inc Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.2.5 Merck & Co Inc Recent Developments
5.3 Eli Lilly and Company
5.3.1 Eli Lilly and Company Profile
5.3.2 Eli Lilly and Company Main Business
5.3.3 Eli Lilly and Company Tumour Vaccine Products, Services and Solutions
5.3.4 Eli Lilly and Company Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.3.5 BioNTech Recent Developments
5.4 BioNTech
5.4.1 BioNTech Profile
5.4.2 BioNTech Main Business
5.4.3 BioNTech Tumour Vaccine Products, Services and Solutions
5.4.4 BioNTech Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.4.5 BioNTech Recent Developments
5.5 Roche Holding AG
5.5.1 Roche Holding AG Profile
5.5.2 Roche Holding AG Main Business
5.5.3 Roche Holding AG Tumour Vaccine Products, Services and Solutions
5.5.4 Roche Holding AG Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.5.5 Roche Holding AG Recent Developments
5.6 OSE Immunotherapeutics
5.6.1 OSE Immunotherapeutics Profile
5.6.2 OSE Immunotherapeutics Main Business
5.6.3 OSE Immunotherapeutics Tumour Vaccine Products, Services and Solutions
5.6.4 OSE Immunotherapeutics Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.6.5 OSE Immunotherapeutics Recent Developments
5.7 Gritstone Bio
5.7.1 Gritstone Bio Profile
5.7.2 Gritstone Bio Main Business
5.7.3 Gritstone Bio Tumour Vaccine Products, Services and Solutions
5.7.4 Gritstone Bio Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.7.5 Gritstone Bio Recent Developments
5.8 Moderna
5.8.1 Moderna Profile
5.8.2 Moderna Main Business
5.8.3 Moderna Tumour Vaccine Products, Services and Solutions
5.8.4 Moderna Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.8.5 Moderna Recent Developments
5.9 Avidea Technologies
5.9.1 Avidea Technologies Profile
5.9.2 Avidea Technologies Main Business
5.9.3 Avidea Technologies Tumour Vaccine Products, Services and Solutions
5.9.4 Avidea Technologies Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.9.5 Avidea Technologies Recent Developments
5.10 Vaccibody AS
5.10.1 Vaccibody AS Profile
5.10.2 Vaccibody AS Main Business
5.10.3 Vaccibody AS Tumour Vaccine Products, Services and Solutions
5.10.4 Vaccibody AS Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.10.5 Vaccibody AS Recent Developments
5.11 Agenus Inc
5.11.1 Agenus Inc Profile
5.11.2 Agenus Inc Main Business
5.11.3 Agenus Inc Tumour Vaccine Products, Services and Solutions
5.11.4 Agenus Inc Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.11.5 Agenus Inc Recent Developments
5.12 Novogene
5.12.1 Novogene Profile
5.12.2 Novogene Main Business
5.12.3 Novogene Tumour Vaccine Products, Services and Solutions
5.12.4 Novogene Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.12.5 Novogene Recent Developments
5.13 ZIOPHARM Oncology
5.13.1 ZIOPHARM Oncology Profile
5.13.2 ZIOPHARM Oncology Main Business
5.13.3 ZIOPHARM Oncology Tumour Vaccine Products, Services and Solutions
5.13.4 ZIOPHARM Oncology Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.13.5 ZIOPHARM Oncology Recent Developments
5.14 ISA Pharmaceuticals
5.14.1 ISA Pharmaceuticals Profile
5.14.2 ISA Pharmaceuticals Main Business
5.14.3 ISA Pharmaceuticals Tumour Vaccine Products, Services and Solutions
5.14.4 ISA Pharmaceuticals Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.14.5 ISA Pharmaceuticals Recent Developments
5.15 BrightPath Biotherapeutics
5.15.1 BrightPath Biotherapeutics Profile
5.15.2 BrightPath Biotherapeutics Main Business
5.15.3 BrightPath Biotherapeutics Tumour Vaccine Products, Services and Solutions
5.15.4 BrightPath Biotherapeutics Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.15.5 BrightPath Biotherapeutics Recent Developments
5.16 Vaximm AG
5.16.1 Vaximm AG Profile
5.16.2 Vaximm AG Main Business
5.16.3 Vaximm AG Tumour Vaccine Products, Services and Solutions
5.16.4 Vaximm AG Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.16.5 Vaximm AG Recent Developments
5.17 Medigene AG
5.17.1 Medigene AG Profile
5.17.2 Medigene AG Main Business
5.17.3 Medigene AG Tumour Vaccine Products, Services and Solutions
5.17.4 Medigene AG Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.17.5 Medigene AG Recent Developments
5.18 Genocea Biosciences Inc
5.18.1 Genocea Biosciences Inc Profile
5.18.2 Genocea Biosciences Inc Main Business
5.18.3 Genocea Biosciences Inc Tumour Vaccine Products, Services and Solutions
5.18.4 Genocea Biosciences Inc Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.18.5 Genocea Biosciences Inc Recent Developments
5.19 Advaxis
5.19.1 Advaxis Profile
5.19.2 Advaxis Main Business
5.19.3 Advaxis Tumour Vaccine Products, Services and Solutions
5.19.4 Advaxis Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.19.5 Advaxis Recent Developments
5.20 Nouscom
5.20.1 Nouscom Profile
5.20.2 Nouscom Main Business
5.20.3 Nouscom Tumour Vaccine Products, Services and Solutions
5.20.4 Nouscom Tumour Vaccine Revenue (US$ Million) & (2024-2024)
5.20.5 Nouscom Recent Developments
6 North America
6.1 North America Tumour Vaccine Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Tumour Vaccine Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Tumour Vaccine Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Tumour Vaccine Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Tumour Vaccine Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Tumour Vaccine Market Dynamics
11.1 Tumour Vaccine Industry Trends
11.2 Tumour Vaccine Market Drivers
11.3 Tumour Vaccine Market Challenges
11.4 Tumour Vaccine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Tumour Vaccine Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Tumour Vaccine Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Tumour Vaccine Market Size Share by Region (2024-2024)
Table 4. Global Tumour Vaccine Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Tumour Vaccine Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Tumour Vaccine Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Tumour Vaccine Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Tumour Vaccine Revenue Market Share by Type (2024-2024)
Table 9. Global Tumour Vaccine Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Tumour Vaccine Revenue Market Share by Type (2024-2034)
Table 11. North America Tumour Vaccine Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Tumour Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Tumour Vaccine Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Tumour Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Tumour Vaccine Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Tumour Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Tumour Vaccine Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Tumour Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Tumour Vaccine Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Tumour Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Tumour Vaccine Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Tumour Vaccine Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Tumour Vaccine Revenue Market Share by Application (2024-2024)
Table 24. Global Tumour Vaccine Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Tumour Vaccine Revenue Market Share by Application (2024-2034)
Table 26. North America Tumour Vaccine Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Tumour Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Tumour Vaccine Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Tumour Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Tumour Vaccine Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Tumour Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Tumour Vaccine Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Tumour Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Tumour Vaccine Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Tumour Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Tumour Vaccine Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Tumour Vaccine Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tumour Vaccine as of 2022)
Table 39. Date of Key Players Enter into Tumour Vaccine Market
Table 40. Global Tumour Vaccine Key Players Headquarters and Area Served
Table 41. Tumour Vaccine Product Solution and Service
Table 42. Global Tumour Vaccine Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Pfizer Basic Information List
Table 45. Pfizer Description and Business Overview
Table 46. Pfizer Tumour Vaccine Products, Services and Solutions
Table 47. Revenue (US$ Million) in Tumour Vaccine Business of Pfizer (2024-2024)
Table 48. Pfizer Recent Developments
Table 49. Merck & Co Inc Basic Information List
Table 50. Merck & Co Inc Description and Business Overview
Table 51. Merck & Co Inc Tumour Vaccine Products, Services and Solutions
Table 52. Revenue (US$ Million) in Tumour Vaccine Business of Merck & Co Inc (2024-2024)
Table 53. Merck & Co Inc Recent Developments
Table 54. Eli Lilly and Company Basic Information List
Table 55. Eli Lilly and Company Description and Business Overview
Table 56. Eli Lilly and Company Tumour Vaccine Products, Services and Solutions
Table 57. Revenue (US$ Million) in Tumour Vaccine Business of Eli Lilly and Company (2024-2024)
Table 58. Eli Lilly and Company Recent Developments
Table 59. BioNTech Basic Information List
Table 60. BioNTech Description and Business Overview
Table 61. BioNTech Tumour Vaccine Products, Services and Solutions
Table 62. Revenue (US$ Million) in Tumour Vaccine Business of BioNTech (2024-2024)
Table 63. BioNTech Recent Developments
Table 64. Roche Holding AG Basic Information List
Table 65. Roche Holding AG Description and Business Overview
Table 66. Roche Holding AG Tumour Vaccine Products, Services and Solutions
Table 67. Revenue (US$ Million) in Tumour Vaccine Business of Roche Holding AG (2024-2024)
Table 68. Roche Holding AG Recent Developments
Table 69. OSE Immunotherapeutics Basic Information List
Table 70. OSE Immunotherapeutics Description and Business Overview
Table 71. OSE Immunotherapeutics Tumour Vaccine Products, Services and Solutions
Table 72. Revenue (US$ Million) in Tumour Vaccine Business of OSE Immunotherapeutics (2024-2024)
Table 73. OSE Immunotherapeutics Recent Developments
Table 74. Gritstone Bio Basic Information List
Table 75. Gritstone Bio Description and Business Overview
Table 76. Gritstone Bio Tumour Vaccine Products, Services and Solutions
Table 77. Revenue (US$ Million) in Tumour Vaccine Business of Gritstone Bio (2024-2024)
Table 78. Gritstone Bio Recent Developments
Table 79. Moderna Basic Information List
Table 80. Moderna Description and Business Overview
Table 81. Moderna Tumour Vaccine Products, Services and Solutions
Table 82. Revenue (US$ Million) in Tumour Vaccine Business of Moderna (2024-2024)
Table 83. Moderna Recent Developments
Table 84. Avidea Technologies Basic Information List
Table 85. Avidea Technologies Description and Business Overview
Table 86. Avidea Technologies Tumour Vaccine Products, Services and Solutions
Table 87. Revenue (US$ Million) in Tumour Vaccine Business of Avidea Technologies (2024-2024)
Table 88. Avidea Technologies Recent Developments
Table 89. Vaccibody AS Basic Information List
Table 90. Vaccibody AS Description and Business Overview
Table 91. Vaccibody AS Tumour Vaccine Products, Services and Solutions
Table 92. Revenue (US$ Million) in Tumour Vaccine Business of Vaccibody AS (2024-2024)
Table 93. Vaccibody AS Recent Developments
Table 94. Agenus Inc Basic Information List
Table 95. Agenus Inc Description and Business Overview
Table 96. Agenus Inc Tumour Vaccine Products, Services and Solutions
Table 97. Revenue (US$ Million) in Tumour Vaccine Business of Agenus Inc (2024-2024)
Table 98. Agenus Inc Recent Developments
Table 99. Novogene Basic Information List
Table 100. Novogene Description and Business Overview
Table 101. Novogene Tumour Vaccine Products, Services and Solutions
Table 102. Revenue (US$ Million) in Tumour Vaccine Business of Novogene (2024-2024)
Table 103. Novogene Recent Developments
Table 104. ZIOPHARM Oncology Basic Information List
Table 105. ZIOPHARM Oncology Description and Business Overview
Table 106. ZIOPHARM Oncology Tumour Vaccine Products, Services and Solutions
Table 107. Revenue (US$ Million) in Tumour Vaccine Business of ZIOPHARM Oncology (2024-2024)
Table 108. ZIOPHARM Oncology Recent Developments
Table 109. ISA Pharmaceuticals Basic Information List
Table 110. ISA Pharmaceuticals Description and Business Overview
Table 111. ISA Pharmaceuticals Tumour Vaccine Products, Services and Solutions
Table 112. Revenue (US$ Million) in Tumour Vaccine Business of ISA Pharmaceuticals (2024-2024)
Table 113. ISA Pharmaceuticals Recent Developments
Table 114. BrightPath Biotherapeutics Basic Information List
Table 115. BrightPath Biotherapeutics Description and Business Overview
Table 116. BrightPath Biotherapeutics Tumour Vaccine Products, Services and Solutions
Table 117. Revenue (US$ Million) in Tumour Vaccine Business of BrightPath Biotherapeutics (2024-2024)
Table 118. BrightPath Biotherapeutics Recent Developments
Table 119. Vaximm AG Basic Information List
Table 120. Vaximm AG Description and Business Overview
Table 121. Vaximm AG Tumour Vaccine Products, Services and Solutions
Table 122. Revenue (US$ Million) in Tumour Vaccine Business of Vaximm AG (2024-2024)
Table 123. Vaximm AG Recent Developments
Table 124. Medigene AG Basic Information List
Table 125. Medigene AG Description and Business Overview
Table 126. Medigene AG Tumour Vaccine Products, Services and Solutions
Table 127. Revenue (US$ Million) in Tumour Vaccine Business of Medigene AG (2024-2024)
Table 128. Medigene AG Recent Developments
Table 129. Genocea Biosciences Inc Basic Information List
Table 130. Genocea Biosciences Inc Description and Business Overview
Table 131. Genocea Biosciences Inc Tumour Vaccine Products, Services and Solutions
Table 132. Revenue (US$ Million) in Tumour Vaccine Business of Genocea Biosciences Inc (2024-2024)
Table 133. Genocea Biosciences Inc Recent Developments
Table 134. Advaxis Basic Information List
Table 135. Advaxis Description and Business Overview
Table 136. Advaxis Tumour Vaccine Products, Services and Solutions
Table 137. Revenue (US$ Million) in Tumour Vaccine Business of Advaxis (2024-2024)
Table 138. Advaxis Recent Developments
Table 139. Nouscom Basic Information List
Table 140. Nouscom Description and Business Overview
Table 141. Nouscom Tumour Vaccine Products, Services and Solutions
Table 142. Revenue (US$ Million) in Tumour Vaccine Business of Nouscom (2024-2024)
Table 143. Nouscom Recent Developments
Table 144. North America Tumour Vaccine Market Size by Country (2024-2024) & (US$ Million)
Table 145. North America Tumour Vaccine Market Size by Country (2024-2034) & (US$ Million)
Table 146. Europe Tumour Vaccine Market Size by Country (2024-2024) & (US$ Million)
Table 147. Europe Tumour Vaccine Market Size by Country (2024-2034) & (US$ Million)
Table 148. Asia-Pacific Tumour Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 149. Asia-Pacific Tumour Vaccine Market Size by Region (2024-2024) & (US$ Million)
Table 150. Asia-Pacific Tumour Vaccine Market Size by Region (2024-2034) & (US$ Million)
Table 151. Asia-Pacific Tumour Vaccine Market Share by Region (2024-2024)
Table 152. Asia-Pacific Tumour Vaccine Market Share by Region (2024-2034)
Table 153. Latin America Tumour Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 154. Latin America Tumour Vaccine Market Size by Country (2024-2024) & (US$ Million)
Table 155. Latin America Tumour Vaccine Market Size by Country (2024-2034) & (US$ Million)
Table 156. Middle East & Africa Tumour Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 157. Middle East & Africa Tumour Vaccine Market Size by Country (2024-2024) & (US$ Million)
Table 158. Middle East & Africa Tumour Vaccine Market Size by Country (2024-2034) & (US$ Million)
Table 159. Tumour Vaccine Market Trends
Table 160. Tumour Vaccine Market Drivers
Table 161. Tumour Vaccine Market Challenges
Table 162. Tumour Vaccine Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumour Vaccine Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Tumour Vaccine Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Tumour Vaccine Market Share by Regions: 2022 VS 2034
Figure 4. Global Tumour Vaccine Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Tumour Vaccine Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Tumour Vaccine Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Tumour Vaccine Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Tumour Vaccine Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Tumour Vaccine Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Personalized Vaccine
Figure 11. Global Personalized Vaccine Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Off-the shelf Vaccine
Figure 13. Global Off-the shelf Vaccine Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Tumour Vaccine Market Size Share by Type: 2022 & 2034
Figure 15. North America Tumour Vaccine Revenue Market Share by Type (2024-2034)
Figure 16. Europe Tumour Vaccine Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Tumour Vaccine Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Tumour Vaccine Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Tumour Vaccine Revenue Market Share by Type (2024-2034)
Figure 20. Lung Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Melanoma Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Gastrointestinal Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Brain Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 24. Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Global Tumour Vaccine Market Size Share by Application: 2022 & 2034
Figure 26. North America Tumour Vaccine Revenue Market Share by Application (2024-2034)
Figure 27. Europe Tumour Vaccine Revenue Market Share by Application (2024-2034)
Figure 28. Asia-Pacific Tumour Vaccine Revenue Market Share by Application (2024-2034)
Figure 29. Latin America Tumour Vaccine Revenue Market Share by Application (2024-2034)
Figure 30. Middle East and Africa Tumour Vaccine Revenue Market Share by Application (2024-2034)
Figure 31. Tumour Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 32. Global Top 5 and Top 10 Players Tumour Vaccine Market Share in 2022
Figure 33. North America Tumour Vaccine Market Share by Country (2024-2034)
Figure 34. United States Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 35. Canada Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 36. Germany Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 37. France Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 38. U.K. Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 39. Italy Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 40. Russia Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 41. Nordic Countries Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 42. Asia-Pacific Tumour Vaccine Market Share by Region (2024-2034)
Figure 43. China Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 44. Japan Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 45. South Korea Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 46. Southeast Asia Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 47. India Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 48. Australia Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 49. Latin America Tumour Vaccine Market Share by Country (2024-2034)
Figure 50. Mexico Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 51. Brazil Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 52. Middle East & Africa Tumour Vaccine Market Share by Country (2024-2034)
Figure 53. Turkey Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 54. Saudi Arabia Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 55. UAE Tumour Vaccine Market Size (2024-2034) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report